IVASMART 7.5
-48%

IVASMART 7.5

Original price was: ₹231.60.Current price is: ₹120.00.

IVASMART 7.5

Original price was: ₹231.60.Current price is: ₹120.00.

Add to cart
Buy Now
Category: Tag:

Ivasmart 7.5mg Tablet is prescribed primarily for managing angina, a condition characterized by heart-related chest pain, as well as for treating chronic heart failure. This medication enhances the heart’s efficiency by reducing the heart rate, which helps alleviate chest discomfort and minimizes the risk of hospitalization for individuals suffering from heart failure. The specific dosage of Ivasmart is determined by the condition being treated. Since both angina and heart failure usually require ongoing treatment, it is essential not to discontinue the medicine without first consulting a healthcare professional. Ivasmart should be taken with meals at a consistent time each day to optimize its effectiveness. Overdosing can lead to excessive slowing of the heart rate, potentially resulting in symptoms such as shortness of breath or fatigue. In such cases, it is crucial to seek immediate medical advice. Commonly reported side effects include temporary visual disturbances, reduced heart rate, elevated blood pressure, irregular heartbeat, lightheadedness, blurred vision, and changes in ECG readings. Some adverse effects, including fainting and marked alterations in heart rhythm, can be serious, necessitating urgent medical intervention. It is advised to refrain from operating a vehicle until you are fully aware of how Ivasmart affects you. This medication is contraindicated in individuals with severe liver disease, very low resting heart rates, or specific heart rhythm disorders, as well as those with significantly low blood pressure or recently aggravated heart failure. Ivasmart may interact with other medications used for hypertension, fungal infections, and HIV. It is not recommended in pregnancy or while breastfeeding.

Reviews

There are no reviews yet.

Be the first to review “IVASMART 7.5”

Your email address will not be published. Required fields are marked *

Top